171 related articles for article (PubMed ID: 20156433)
1. Alpha-actinin 1 and alpha-actinin 4: contrasting roles in the survival, motility, and RhoA signaling of astrocytoma cells.
Quick Q; Skalli O
Exp Cell Res; 2010 Apr; 316(7):1137-47. PubMed ID: 20156433
[TBL] [Abstract][Full Text] [Related]
2. Identification of cadherin-11 down-regulation as a common response of astrocytoma cells to transforming growth factor-alpha.
Zhou R; Skalli O
Differentiation; 2000 Dec; 66(4-5):165-72. PubMed ID: 11269942
[TBL] [Abstract][Full Text] [Related]
3. p16(ink4a) and retinoic acid modulate rhoA and GFAP expression during induction of a stellate phenotype in U343 MG-A astrocytoma cells.
Langlois A; Lee S; Kim DS; Dirks PB; Rutka JT
Glia; 2002 Oct; 40(1):85-94. PubMed ID: 12237846
[TBL] [Abstract][Full Text] [Related]
4. [Expression of cytokine genes within astrocytoma cell lines and brain specimens].
Nitta T; Steinman L; Sato K
No To Shinkei; 1991 Dec; 43(12):1145-50. PubMed ID: 1799521
[TBL] [Abstract][Full Text] [Related]
5. Intermediate filament protein synemin is present in human reactive and malignant astrocytes and associates with ruffled membranes in astrocytoma cells.
Jing R; Pizzolato G; Robson RM; Gabbiani G; Skalli O
Glia; 2005 Apr; 50(2):107-20. PubMed ID: 15657940
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation-mediated down-regulation of CXCL12 in human astrocytoma.
Zhou W; Jiang Z; Song X; Liu Y; Wen P; Guo Y; Xu F; Kong L; Zhang P; Han A; Yu J
J Neurosci Res; 2008 Oct; 86(13):3002-10. PubMed ID: 18512766
[TBL] [Abstract][Full Text] [Related]
8. Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I-III astrocytomas.
Li D; Chen P; Li XY; Zhang LY; Xiong W; Zhou M; Xiao L; Zeng F; Li XL; Wu MH; Li GY
OMICS; 2011 Oct; 15(10):673-82. PubMed ID: 21978395
[TBL] [Abstract][Full Text] [Related]
9. Expression pattern of alpha-protein kinase C in human astrocytomas indicates a role in malignant progression.
Benzil DL; Finkelstein SD; Epstein MH; Finch PW
Cancer Res; 1992 May; 52(10):2951-6. PubMed ID: 1316231
[TBL] [Abstract][Full Text] [Related]
10. Identification of MG-160, a FGF binding medial Golgi sialoglycoprotein, in brain tumors: an index of malignancy in astrocytomas.
Yamaguchi F; Morrison RS; Gonatas NK; Takahashi H; Sugisaki Y; Teramoto A
Int J Oncol; 2003 May; 22(5):1045-9. PubMed ID: 12684670
[TBL] [Abstract][Full Text] [Related]
11. Drosophila alpha-actinin in ovarian follicle cells is regulated by EGFR and Dpp signalling and required for cytoskeletal remodelling.
Wahlström G; Norokorpi HL; Heino TI
Mech Dev; 2006 Nov; 123(11):801-18. PubMed ID: 17008069
[TBL] [Abstract][Full Text] [Related]
12. DLC2/StarD13 plays a role of a tumor suppressor in astrocytoma.
El-Sitt S; Khalil BD; Hanna S; El-Sabban M; Fakhreddine N; El-Sibai M
Oncol Rep; 2012 Aug; 28(2):511-8. PubMed ID: 22614672
[TBL] [Abstract][Full Text] [Related]
13. Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas.
Wienecke R; Guha A; Maize JC; Heideman RL; DeClue JE; Gutmann DH
Ann Neurol; 1997 Aug; 42(2):230-5. PubMed ID: 9266734
[TBL] [Abstract][Full Text] [Related]
14. [Expression of fibroblast growth factor receptors (FGFRs) mRNA in human astrocytomas].
Yamada SM; Bruner JM; Berger MS; Morrison RS
No To Shinkei; 1996 Apr; 48(4):363-70. PubMed ID: 8679334
[TBL] [Abstract][Full Text] [Related]
15. Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles.
Rorive S; Maris C; Debeir O; Sandras F; Vidaud M; Bièche I; Salmon I; Decaestecker C
J Neuropathol Exp Neurol; 2006 Aug; 65(8):794-807. PubMed ID: 16896313
[TBL] [Abstract][Full Text] [Related]
16. An identification of stem cell-resembling gene expression profiles in high-grade astrocytomas.
Yang Y; Qiu Y; Ren W; Gong J; Chen F
Mol Carcinog; 2008 Nov; 47(11):893-903. PubMed ID: 18395814
[TBL] [Abstract][Full Text] [Related]
17. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
18. The chemokine GRO-alpha (CXCL1) confers increased tumorigenicity to glioma cells.
Zhou Y; Zhang J; Liu Q; Bell R; Muruve DA; Forsyth P; Arcellana-Panlilio M; Robbins S; Yong VW
Carcinogenesis; 2005 Dec; 26(12):2058-68. PubMed ID: 16033775
[TBL] [Abstract][Full Text] [Related]
19. The human non-muscle alpha-actinin protein encoded by the ACTN4 gene suppresses tumorigenicity of human neuroblastoma cells.
Nikolopoulos SN; Spengler BA; Kisselbach K; Evans AE; Biedler JL; Ross RA
Oncogene; 2000 Jan; 19(3):380-6. PubMed ID: 10656685
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival.
Li J; Guan HY; Gong LY; Song LB; Zhang N; Wu J; Yuan J; Zheng YJ; Huang ZS; Li M
Clin Cancer Res; 2008 Nov; 14(21):6996-7003. PubMed ID: 18980995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
